---
title: "InMed Pharmaceuticals surges 33% during regular trading on heavy volume"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293482109.md"
description: "InMed Pharmaceuticals (INM) jumped 33% to $2.05 in regular trading after surging over 80% in premarket session."
datetime: "2026-07-22T13:40:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293482109.md)
  - [en](https://longbridge.com/en/news/293482109.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293482109.md)
---

# InMed Pharmaceuticals surges 33% during regular trading on heavy volume

InMed Pharmaceuticals(INM.US) 盘中涨超 33%，现报 2.05 美元。

该股盘前交易中一度飙升逾 80%，被列入周三盘前医疗保健板块异动股票名单，与 Lakewood-Amedex、China SXT Pharmaceuticals 等医药股同步异动。盘中成交量达**3906.49**万股，触发多次 5 分钟急涨及急跌信号，股价在高**2.33**美元与低**2.04**美元间大幅波动。

消息面暂无明显驱动。

### Related Stocks

- [INM.US](https://longbridge.com/en/quote/INM.US.md)

## Related News & Research

- [Mentari Therapeutics merger with InMed set to close ahead of USD 200 million private placement](https://longbridge.com/en/news/293462774.md)
- [InMed amends merger deal with Mentari, files S-4 registration statement](https://longbridge.com/en/news/292353581.md)
- [InMed Pharmaceuticals amends merger pact with Mentari Therapeutics](https://longbridge.com/en/news/291880249.md)
- [Vivo Opportunity reports $9,963 purchase of InMed Pharma common shares](https://longbridge.com/en/news/291596941.md)
- [Vivo Opportunity reports USD 32,319 purchase of InMed common shares](https://longbridge.com/en/news/292970986.md)